InsidersTradesSigma
Follow the ARTRYA LIMITED stock price and the full management transaction log of the company, a listed issuer based in Australia. Shares trade on AU AU, under the authority of ASX. The latest transaction was reported on 10 July 2026 (Sale). Among the most active insiders: Bernie Ridgeway. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
ARTRYA LIMITED is a company listed on the XASX, focused on developing technological solutions for cardiac health. It aims to enhance the diagnosis and treatment of cardiovascular diseases.